Literature DB >> 30413319

Total versus subtotal parathyroidectomy for secondary hyperparathyroidism.

Elin Isaksson1, Kerstin Ivarsson2, Shahriar Akaberi2, Andreas Muth3, Karl-Göran Prütz4, Naomi Clyne2, Gunnar Sterner1, Martin Almquist5.   

Abstract

BACKGROUND: It remains unclear whether total or subtotal parathyroidectomy for secondary hyperparathyroidism yields the best outcomes. We investigated mortality, cardiovascular events, hip fracture, and recurrent parathyroidectomy after total versus subtotal parathyroidectomy in patients on renal replacement therapy.
METHODS: Using the Swedish Renal Registry, the surgical registry for thyroid and parathyroid surgery, and the National Inpatient Registry, we identified patients who underwent parathyroidectomy between 1991 and 2013. We calculated the risk of outcome after total versus subtotal parathyroidectomy using COX's regression, adjusting for age, sex, cause of renal disease, time with a functioning graft before and after parathyroidectomy, Charlson comorbidity index, year of surgery, prevalent cardiovascular disease, time on dialysis, renal transplantation at parathyroidectomy, and treatment with calcimimetics before parathyroidectomy.
RESULTS: There were 824 patients who underwent parathyroidectomy, 388 total and 436 subtotal. There was no difference in mortality or risk of incident hip fracture between groups. Comparing the subtotal with the total parathyroidectomy, the adjusted hazard ratio (95% confidence interval) for cardiovascular events was 0.43 (0.25-0.72) and for recurrent parathyroidectomy 3.33 (1.33-8.32).
CONCLUSION: There was a higher risk of cardiovascular events in patients after total parathyroidectomy compared with subtotal parathyroidectomy, but a lower risk of recurrent parathyroidectomy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30413319     DOI: 10.1016/j.surg.2018.04.076

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Serum nuclear factor IB as a novel and noninvasive indicator in the diagnosis of secondary hyperparathyroidism.

Authors:  Jian'gen Yu; Yu Song; Aihua Yang; Xiaoyun Zhang; Lin Li
Journal:  J Clin Lab Anal       Date:  2021-05-15       Impact factor: 2.352

2.  A Meta-Analysis of Risk Factors for Transient and Permanent Hypocalcemia After Total Thyroidectomy.

Authors:  Yuan Qin; Wei Sun; Zhihong Wang; Wenwu Dong; Liang He; Ting Zhang; Hao Zhang
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

3.  Diagnostic Accuracy of Intraoperative Intact Parathyroid Hormone Monitoring for Surgical Outcomes of Secondary Hyperparathyroidism.

Authors:  Yuanyuan Chen; Bin Liang; Xiaofeng Dong; Tao Huang; Tian-Qi Liu
Journal:  Med Sci Monit       Date:  2021-11-28

4.  Use of intraoperative parathyroid hormone measurements during parathyroidectomy to predict postoperative parathyroid hormone levels in patients with renal hyperparathyroidism: meta-analysis.

Authors:  Dirk-Jan van Beek; Stina Fredriksson; Stefanie Haegele; Marco Raffaelli; Philipp Riss; Martin Almquist
Journal:  BJS Open       Date:  2022-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.